comparemela.com

Jerel Davis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vancouver readies for its position as a global pharma capital as B C s biotech boom takes off

Vancouver readies for its position as a global pharma capital as B C s biotech boom takes off
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesSan franciscoNew yorkFalse creekBritish columbiaBurrard inletJerel davisErin bedfordLaurent pelissierGray mcleanSriram subramaniamHelen burtMichael galloMichael hayden

Firefly Bio Debuts With $94 Million Series A Financing

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Feb 15, 2024

United statesSouth san franciscoJerel davisCarolyn bertozziTodd foleyBernhard geierstangerScott hirschSteve edelsonJohn flygareBasel technology parkEli lilly companyLeadership teamVersant venturesDecheng capitalEli lillyRidgeline discovery engine

Versant-backed Firefly Bio wants to make the next generation of ADCs

BioPharma

United statesCarolyn bertozziEli lillyBernhard geierstangerJerel davisDaiichi sankyoJohn flygareScott hirschAstrazeneca enhertuBristol myers squibbDive briefVersant venturesDecheng capitalOrum therapeutics

Firefly Bio assembles with $94M and an ADC dream team

Firefly Bio assembles with $94M and an ADC dream team
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Jerel davisScott hirschMablink bioscienceEli lillyJohn flygareCarolyn bertozziBernhard geierstangerMerck coBristol myers squibbVersant venture ridgelineDecheng capitalVentures managing director jerel davisChief scientific officer john flygareNurix therapeuticsAlly bridge groupLilly asia ventures

Firefly Bio Debuts With $94 Million Series A Financing

Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Firefly Bio emerged from stealth mode with a $94 million Series A financing co-led b.

Todd foleyBernhard geierstangerScott hirschCarolyn bertozziJerel davisJohn flygareEli lilly companyBasel technology parkLeadership teamVersant venturesDecheng capitalEli lillyFirefly bioRidgeline discovery engineBasel technologyManaging director

vimarsana © 2020. All Rights Reserved.